Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hellberg

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|November 13, 2004
Beta-oxygenated analogues of the 5-HT2A serotonin receptor agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropaneRichard A Glennon, Mikhail L Bondarev, Nantaka Khorana, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2007
Novel benzodifuran analogs as potent 5-HT2A receptor agonists with ocular hypotensive activityZixia Feng, Suchismita Mohapatra, Peter G Klimko, et al.
Experimental Eye Research|October 22, 2002
Suppression of post-vitrectomy lens changes in the rabbit by novel benzopyranyl esters and amidesJ R Kuszak, J G Sivak, K L Moran, et al.
Investigative Ophthalmology & Visual Science|March 26, 2005
Evaluation of inducible nitric oxide synthase in glaucomatous optic neuropathy and pressure-induced optic nerve damageIok-Hou Pang, Elaine C Johnson, Lijun Jia, et al.
Bioorganic & Medicinal Chemistry Letters|December 22, 2009
2,3-Diaminopyrazines as Rho kinase inhibitorsAlan J Henderson, Mark Hadden, Cheng Guo, et al.
Journal of Medicinal Chemistry|November 10, 2015
Ocular Hypotensive Response in Nonhuman Primates of (8R)-1-[(2S)-2-Aminopropyl]-8,9-dihydro-7H-pyrano[2,3-g]indazol-8-ol a Selective 5-HT2 Receptor AgonistJesse A May, Najam A Sharif, Marsha A McLaughlin, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2014
In vivo optimization of 2,3-diaminopyrazine Rho Kinase inhibitors for the treatment of glaucomaHwang-Hsing Chen, Abdelmoulah Namil, Bryon Severns, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
AL-12182, a novel 11-oxa prostaglandin analog with topical ocular hypotensive activity in the monkeyRobert D Selliah, Mark R Hellberg, Najam A Sharif, et al.
Bioorganic & Medicinal Chemistry Letters|May 4, 2010
Benzothiophene containing Rho kinase inhibitors: Efficacy in an animal model of glaucomaRobert L Davis, Mehmet Kahraman, Thomas J Prins, et al.
Bioorganic & Medicinal Chemistry|April 9, 2002
3-Oxa-15-cyclohexyl prostaglandin DP receptor agonists as topical antiglaucoma agentsMark R Hellberg, Raymond E Conrow, Najam A Sharif, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|November 13, 2004
Beta-oxygenated analogues of the 5-HT2A serotonin receptor agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropaneRichard A Glennon, Mikhail L Bondarev, Nantaka Khorana, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2007
Novel benzodifuran analogs as potent 5-HT2A receptor agonists with ocular hypotensive activityZixia Feng, Suchismita Mohapatra, Peter G Klimko, et al.
Experimental Eye Research|October 22, 2002
Suppression of post-vitrectomy lens changes in the rabbit by novel benzopyranyl esters and amidesJ R Kuszak, J G Sivak, K L Moran, et al.
Investigative Ophthalmology & Visual Science|March 26, 2005
Evaluation of inducible nitric oxide synthase in glaucomatous optic neuropathy and pressure-induced optic nerve damageIok-Hou Pang, Elaine C Johnson, Lijun Jia, et al.
Bioorganic & Medicinal Chemistry Letters|December 22, 2009
2,3-Diaminopyrazines as Rho kinase inhibitorsAlan J Henderson, Mark Hadden, Cheng Guo, et al.
Journal of Medicinal Chemistry|November 10, 2015
Ocular Hypotensive Response in Nonhuman Primates of (8R)-1-[(2S)-2-Aminopropyl]-8,9-dihydro-7H-pyrano[2,3-g]indazol-8-ol a Selective 5-HT2 Receptor AgonistJesse A May, Najam A Sharif, Marsha A McLaughlin, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2014
In vivo optimization of 2,3-diaminopyrazine Rho Kinase inhibitors for the treatment of glaucomaHwang-Hsing Chen, Abdelmoulah Namil, Bryon Severns, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
AL-12182, a novel 11-oxa prostaglandin analog with topical ocular hypotensive activity in the monkeyRobert D Selliah, Mark R Hellberg, Najam A Sharif, et al.
Bioorganic & Medicinal Chemistry Letters|May 4, 2010
Benzothiophene containing Rho kinase inhibitors: Efficacy in an animal model of glaucomaRobert L Davis, Mehmet Kahraman, Thomas J Prins, et al.
Bioorganic & Medicinal Chemistry|April 9, 2002
3-Oxa-15-cyclohexyl prostaglandin DP receptor agonists as topical antiglaucoma agentsMark R Hellberg, Raymond E Conrow, Najam A Sharif, et al.
Pageof 4